Get started
Author

María Tristán‐Manzano

Observed names: M. Tristán-Manzano, M. Tristán-Manzano¹, Maria Tristan-Manzano, Maria Tristán-Manzano, María Tristán-Manzano, Tristán Manzano, María, Tristán-Manzano, María
Observed institutions: Universidad de Granada, Instituto de Investigación Biosanitaria de Granada, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research, Instituto Murciano de Investigación Biosanitaria, Parque Tecnológico de la Salud, Universidad de Murcia
ORCID: 0000-0001-8721-1414
Observed ORCID: 0000-0001-8721-1414
OpenAlex ID: A5022435677
Exosome: A New Player in Translational Nanomedicine
2020 · Houssam Aheget, María Tristán-Manzano, et al. · Journal of Clinical Medicine · 96
PDF
Characterization of human peritoneal monocyte/macrophage subsets in homeostasis: Phenotype, GATA6, phagocytic/oxidative activities and cytokines expression
2018 · Antonio José Ruiz-Alcaraz, Violeta Carmona-Martínez, et al. · Scientific Reports · 64
PDF
Anti-CD44-Conjugated Olive Oil Liquid Nanocapsules for Targeting Pancreatic Cancer Stem Cells
2021 · Saúl A. Navarro-Marchal, Carmen Griñán-Lisón, et al. · Biomacromolecules · 50
PDF
Using Gene Editing Approaches to Fine-Tune the Immune System
2020 · Kristina Pavlovic, María Tristán-Manzano, et al. · Frontiers in Immunology · 50
CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?
2024 · Carlos Rangel-Peláez, Laura Martínez-Gutiérrez, et al. · Frontiers in Immunology · 33
PDF
Externally-Controlled Systems for Immunotherapy: From Bench to Bedside
2020 · María Tristán-Manzano, Pedro Justicia-Lirio, et al. · Frontiers in Immunology · 33
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
2022 · Noelia Maldonado-Pérez, María Tristán-Manzano, et al. · Frontiers in Immunology · 29
Physiological lentiviral vectors for the generation of improved CAR-T cells
2022 · María Tristán-Manzano, Noelia Maldonado-Pérez, et al. · Molecular Therapy — Oncolytics · 27
PDF
A novel CD14high CD16high subset of peritoneal macrophages from cirrhotic patients is associated to an increased response to LPS
2016 · Antonio José Ruiz-Alcaraz, Ana Tapia-Abellán, et al. · Molecular Immunology · 26
Tailoring CAR surface density and dynamics to improve CAR-T cell therapy
2025 · Ana Hinckley-Boned, Carmen Barbero-Jiménez, et al. · Journal for ImmunoTherapy of Cancer · 21
Genome-edited adult stem cells: Next-generation advanced therapy medicinal products
2020 · Karim Benabdellah, Sabina Sánchez-Hernández, et al. · Stem Cells Translational Medicine · 21
Isolation of functional mature peritoneal macrophages from healthy humans
2019 · Antonio J Ruiz‐Alcaraz, Helios Martínez‐Banaclocha, et al. · Immunology and Cell Biology · 21
Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome
2024 · Kristina Pavlovic, MDolores Carmona-Luque, et al. · Frontiers in Immunology · 20
PDF
Stable Genetic Modification of Mesenchymal Stromal Cells Using Lentiviral Vectors
2019 · Francisco Martín, María Tristán-Manzano, et al. · Methods in molecular biology · 15
The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes
2018 · Sabina Sánchez-Hernández, Alejandra Gutierrez-Guerrero, et al. · Molecular Therapy — Nucleic Acids · 13
Risk and Benefit Assessment of Gene Therapy with Lentiviral Vectors and Hematopoietic Stem Cells: The Skysona Case
2025 · Pilar Puig-Serra, Ana Hinckley-Boned, et al. · Human Gene Therapy · 11
Quinoxalines Potential to Target Pathologies
2015 · Maria Tristan-Manzano, Antonio Guirado, et al. · Current Medicinal Chemistry · 11
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
2023 · María Tristán-Manzano, Noelia Maldonado-Pérez, et al. · Molecular Therapy — Nucleic Acids · 10
PDF
Intracellular signaling modifications involved in the anti-inflammatory effect of 4-alkoxy-6,9-dichloro[1,2,4]triazolo[4,3-a]quinoxalines on macrophages
2017 · Antonio J. Ruiz-Alcaraz, María Tristán-Manzano, et al. · European Journal of Pharmaceutical Sciences · 9
First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas
2024 · Pedro Justicia-Lirio, María Tristán-Manzano, et al. · Molecular Therapy — Nucleic Acids · 8
Improved Functionality of Integration-Deficient Lentiviral Vectors (IDLVs) by the Inclusion of IS2 Protein Docks
2021 · Marina Cortijo-Gutiérrez, Sabina Sánchez-Hernández, et al. · Pharmaceutics · 7
WAS Promoter-Driven Lentiviral Vectors Mimic Closely the Lopsided WASP Expression during Megakaryocytic Differentiation
2020 · Pilar Muñoz, María Tristán-Manzano, et al. · Molecular Therapy — Methods & Clinical Development · 5
PDF
Stem Cells for Modeling Human Disease
2016 · F. Martín, A. Sánchez-Gilabert, et al. · InTech eBooks · 2
PDF
Development and Validation of "awari": an Improved Anti Cd19 Car T Cell for Clinical Use.
2026 · A. Ballesteros- Ribelles, R. Jiménez-Moreno, et al. · Cytotherapy
Design of Chimeric Antigen Receptor (CAR) T Cell Therapy
2026 · María Tristán-Manzano, Jon Ruiz de Franscisco, et al. · Springer eBooks
Works count: 30
Citation count: 582
H-index: 14
I10-index: 18
Year
Topic
Type